MERCILON

This brand name is authorized in Austria, Brazil, Estonia, Finland, France, Hong Kong, Ireland, Israel, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, United Kingdom, South Africa

Active ingredients

The drug MERCILON contains a combination of these active pharmaceutical ingredients (APIs):

1 Desogestrel UNII 81K9V7M3A3 - DESOGESTREL

Desogestrel is a progestogen. Like other progestogen-only pills, desogestrel is best suited for use during breast feeding and for women who may not or do not want to use oestrogens. In contrast to traditional progestogen-only pills, the contraceptive effect of desogestrel is achieved primarily by inhibition of ovulation. Other effects include increased viscosity of the cervical mucus. Read about Desogestrel

2 17 alpha-Ethinylestradiol UNII 423D2T571U - ETHINYL ESTRADIOL

Ethinylestradiol is chemically and biologically identical to endogenous human oestradiol. It substitutes for the loss of estrogen production in menopausal women, and alleviates menopausal symptoms. Estrogens prevent bone loss following menopause or ovariectomy. Read about 17 alpha-Ethinylestradiol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G03AA09	Desogestrel and ethinylestradiol	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03A Hormonal contraceptives for systemic use → G03AA Progestogens and estrogens, fixed combinations
Discover more medicines within G03AA09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 527302101113413, 527303801119315, 527316010018103, 527316010018203
Country: EE	Ravimiamet	Identifier(s): 1062908, 1062919
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 109744, 110395
Country: FR	Base de données publique des médicaments	Identifier(s): 69374160
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 139308, 26196
Country: HK	Department of Health Drug Office	Identifier(s): 33400
Country: IE	Health Products Regulatory Authority	Identifier(s): 31402
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 3029, 3030
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1013172, 1013173, 1013174, 1064031, 1085686, 1085792
Country: MT	Medicines Authority	Identifier(s): MA031/02301, PI770/10101B, PI908/12802A
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 001M93
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 78328
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 3410
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100042774, 100065440, 100266427, 100267970, 100290667, 100292703, 100314333, 100334130, 100344268, 100377055, 100417470, 100417978, 100419902, 100422040
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68120001, W68120002, W68120003
Country: SG	Health Sciences Authority	Identifier(s): 06136P
Country: ZA	Health Products Regulatory Authority	Identifier(s): Y/18.8/78